A
Atieh Amouzegar
Researcher at Shahid Beheshti University of Medical Sciences and Health Services
Publications - 147
Citations - 1813
Atieh Amouzegar is an academic researcher from Shahid Beheshti University of Medical Sciences and Health Services. The author has contributed to research in topics: Population & Euthyroid. The author has an hindex of 21, co-authored 126 publications receiving 1283 citations. Previous affiliations of Atieh Amouzegar include Shahid Beheshti University.
Papers
More filters
Journal ArticleDOI
Metabolic health in the Middle East and north Africa.
Fereidoun Azizi,Farzad Hadaegh,Farhad Hosseinpanah,Parvin Mirmiran,Atieh Amouzegar,Hengameh Abdi,Golaleh Asghari,Donna Parizadeh,Seyed Ali Montazeri,Mojtaba Lotfaliany,Farzin Takyar,Davood Khalili +11 more
TL;DR: Comprehensive surveillance and monitoring of metabolic diseases, robust multisectoral systems that support primordial and primary preventions, continuous education of health-care providers, as well as collaboration between countries for joint projects in this region are urgently needed to overcome the paucity of data.
Journal ArticleDOI
Management of hyperthyroidism during pregnancy and lactation
Fereidoun Azizi,Atieh Amouzegar +1 more
TL;DR: Management of hyperthyroidism during pregnancy and lactation requires special considerations and should be carefully implemented to avoid any adverse effects on the mother, fetus, and neonate.
Journal ArticleDOI
Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects
TL;DR: In euthyroid subjects, FT4, rather than TSH, is associated with risk of metabolic syndrome and its components and the prevalence of other metabolic syndrome components decreased significantly from higher to lower FT4 tertiles.
Journal ArticleDOI
Increased Remission Rates After Long-Term Methimazole Therapy in Patients with Graves' Disease: Results of a Randomized Clinical Trial.
Fereidoun Azizi,Atieh Amouzegar,Maryam Tohidi,Mehdi Hedayati,Davood Khalili,Leila Cheraghi,Yadollah Mehrabi,Miralireza Takyar +7 more
TL;DR: Administration of low-dose methimazole for a total of 60-120 months safely and effectively treats Graves' hyperthyroidism, with much higher remission rates than attained using conventional 18-24-month courses.
Journal ArticleDOI
Thyroid Function and Metabolic Syndrome: A Population-Based Thyroid Study
Ladan Mehran,Atieh Amouzegar,Parnian Kheirkhah Rahimabad,Maryam Tohidi,Zhale Tahmasebinejad,Fereidoun Azizi +5 more
TL;DR: Over and subclinical hyperthyroidism had significantly higher odds of hyperglycemia in men and women after full adjustment for age, smoking, and BMI, and there was higher risk of Mets in subclinically hypothyroid subjects, aged>50.